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The zebrafish (Danio rerio) has been used as a model for studying vertebrate development in the 
cardiovascular system. In order to monitor heart contraction and cytosolic calcium oscillations, 
fish were either embedded in methylcellulose or anesthetized with tricaine. Using high-resolution 
differential interference contrast and calcium imaging microscopy, we here show that dopamine 
and verapamil alter calcium signaling and muscle contraction in anesthetized zebrafish, but not 
in embedded zebrafish. In anesthetized fish, dopamine increases the amplitude of cytosolic 
calcium oscillation with a subsequent increase in heart contraction, whereas verapamil decreases 
the frequency of calcium oscillation and heart rate. Interestingly, verapamil also increases 
myocardial contraction. Our data further indicate that verapamil can increase myocardial calcium 
sensitivity in anesthetized fish. Taken together, our data reinforce in vivo cardiac responses to 
dopamine and verapamil. Furthermore, effects of dopamine and verapamil on myocardial calcium 
and contraction are greater in anesthetized than embedded fish. We suggest that while the 
zebrafish is an excellent model for a cardiovascular imaging study, the cardio-pharmacological 
profiles are very different between anesthetized and embedded fish.
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drug (Langheinrich, 2003; Milan et al., 2003). However, accurate 
measurements of cardiovascular variables can only be achieved by 
immobilizing the fish during recordings.
In this study, we show that the two most used techniques to immo-
bilize the fish can alter pharmacological responses differently, espe-
cially within the cardiovascular system. The effects of dopamine and 
verapamil on fish immobilized with methylcellulose (embedded) or 
tricaine (anesthetized) were analyzed. Dopamine and verapamil were 
selected, because their respective (+)- and (−)-inotropic actions on 
the heart have been well documented. In the present study, we simul-
taneously measured intracellular calcium in the heart and monitored 
the heart muscle in vivo in embedded and anesthetized zebrafish. We 
measure both myocardial calcium and heart contraction in terms of 
oscillations, frequencies, and amplitudes. In addition, we determine 
the effects of dopamine and verapamil on these variables.
Materials and Methods
We used the wild type (WT) strain of zebrafish as our animal model, 
which was purchased from the Zebrafish International Resource 
Center (Eugene, OR, USA). The use of zebrafish was approved by 
The University of Toledo Animal Care and Use committee. All fish 
were studied at approximately 1 week old.
Zebrafish preparation
To enable cytosolic calcium measurement, the fish was incubated 
with 60 μg/mL fluo-4 AM or fura-2 AM (Invitrogen, Inc.) contain-
ing 2.5% DMSO in egg water for 30 min at room temperature. 
introduction
The zebrafish (Danio rerio) has become an important model 
organism for studying various diseases, genetic variations, pro-
tein functions, behavioral selectivity, environmental toxicology, 
and many other physiological responses for high-throughput 
chemical screening (Carvan et al., 2004; Burns et al., 2005; Wessely 
and Obara, 2008; Ingham, 2009). Without doubt, the decision 
to sequence the entire genome of the zebrafish has helped in 
consolidating zebrafish as an experimental model (Vogel, 2000). 
In particular, zebrafish has been used for various genetic and 
 pharmacological studies.
Although the zebrafish was originally used as a model for the 
study of vertebrate development, it has recently been used for 
other studies, largely due to its transparency. In many other ani-
mal models, in vivo physiological imaging of internal organs has 
remained relatively inaccessible. More specifically, calcium imag-
ing using probes has been used in zebrafish in vivo (Huisken et al., 
2004; Ebert et al., 2005; Milan et al., 2006; Arnaout et al., 2007; Chi 
et al., 2008) and confirmed in the isolated heart (Sehnert et al., 
2002; Sedmera et al., 2003; Langenbacher et al., 2005). The pat-
terns of free calcium have also been measured in zebrafish embryos 
(Creton et al., 1998).
Many laboratories have demonstrated substantial similarities 
in the pharmacological responses of the zebrafish heart to a broad 
range of pharmacological agents. More importantly, the therapeu-
tic and toxic responses for both cardiac and non-cardiac drugs 
can be performed by simply immersing the fish in the intended 
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The egg water was composed of 6% NaCl in sterile distilled water 
(Carvan et al., 2004). Whereas fluo-4 was used to enable us to 
capture calcium oscillation at a greater rate (∼1,560 frames/min), 
fura-2 was utilized to obtain a better signal-to-noise fluorescence 
intensity. The fish was then rinsed twice with egg water and briefly 
monitored under a light microscope for heartbeat. At this stage, 
fish with any sign of abnormal heartbeat or agility in swimming 
were discarded. The healthy fish were then transferred in egg water 
containing 50 μg/mL tricaine (Sigma Aldrich, Inc.) for 30 s.
For embedded preparation, sedated fish was mounted in 3% 
methylcellulose (Sigma Aldrich, Inc.). Note that it was necessary to 
briefly sedate the fish in this preparation for a better position and 
control of the fish on our microscope chamber. The fish was then 
placed on a custom-made plate with the depression of a number 1.0 
coverglass in the center. The fish was orientated to its side to achieve 
a desired position for imaging. About 250 μL methylcellulose was 
immediately dropped onto the fish to fill the plate depression, or 
until the fish was secure. Once the methylcellulose was solidified, 
usually in less than a minute at room temperature, the methylcel-
lulose and fish were covered with egg water for the entire duration. 
Although the fish usually recovered in about 5 min, we waited for 
at least 10 min to remove the residual tricaine by changing the 
egg water every 2 min. Recovery of the fish was confirmed with a 
stable heartbeat of about 120 beats/min before any experiments 
were performed.
For tricaine preparation, we have titrated the incubation time 
(5 min) and concentration (50 μg/mL) of tricaine to be optimal 
to stabilize the fish for the duration of our experiments. Sedated 
fish were considered stable when limited physical movements were 
observed. The fish was then transferred to our customized plate 
with glass property optimal for our imaging studies. For the entire 
duration, the fish was covered with egg water.
pharMacological agents
Effects of dopamine (Acros Organics, Inc.) or verapamil (Sigma 
Aldrich, Inc.) on heart contractions were titrated with various con-
centrations of 0, 1, 4, 10, 40, 100, and 400 μg/mL in a total of 150 
independent fish (Tables 1 and 2). For the rest of our studies, we 
chose a dosage of 100 μg/mL for dopamine or 4 μg/mL for vera-
pamil, because these dosages were determined experimentally to 
be the suboptimal concentrations for their effects on the heart con-
tractions in anesthetized fish. More important, these dosages pro-
vided an obvious difference in their physiological effects between 
methylcellulose-embedded and tricaine-treated fish. For all experi-
ments, an equilibration time of at least 1 min with or without drug 
was achieved prior to image recording. In some experiments, pro-
pranolol (Sigma Aldrich, Inc.) were also used with a concentration 
of 0.001, 0.01, 0.1, 1, 3, and 10 μM.
iMage recording
The fish was imaged at the objective magnifications of 2×, 20×, or 
40× with the Nikon Eclipse TE2000-U microscope controlled with 
the Metaflor program as previously described (Nauli et al., 2008; 
AbouAlaiwi et al., 2009). We imaged the fish with all three mag-
nifications for verification purposes. The 2× magnification would 
allow us to monitor the entire body of the fish. Whereas 20× would 
allow us to monitor heart and other organs concurrently (such 
Table 1 | Effects of tricaine and verapamil on heart rate and calcium 
oscillation.
Tricaine Verapamil Heart rate Ca2+ oscillation 
(μg/mL) (μg/mL) (beats/min) (oscillations/min)
 0 0 120 ± 4 121 ± 3
 1 123 ± 3 123 ± 2
 4 116 ± 4 115 ± 2
 10 103 ± 6 109 ± 4
 40 52 ± 10 53 ± 11
 100 0 ± 0 0 ± 0
 400 0 ± 0 0 ± 0
10 0 122 ± 5 121 ± 4
 1 122 ± 5 120 ± 4
 4 102 ± 10 106 ± 6
 10 86 ± 12 89 ± 13
 40 18 ± 7 23 ± 20
 100 0 ± 0 0 ± 0
 400 0 ± 0 0 ± 0
20 0 120 ± 5 119 ± 2
 1 116 ± 6 113 ± 1
 4 102 ± 11 105 ± 3
 10 65 ± 7 61 ± 5
 40 12 ± 5 11 ± 4
 100 0 ± 0 0 ± 0
 400 0 ± 0 0 ± 0
30 0 118 ± 2 118 ± 3
 1 100 ± 5 100 ± 4
 4 90 ± 11 85 ± 9
 10 64 ± 6 64 ± 5
 40 20 ± 12 19 ± 11
 100 0 ± 0 0 ± 0
 400 0 ± 0 0 ± 0
40 0 81 ± 8 82 ± 8
 1 70 ± 8 74 ± 6
 4 50 ± 10 47 ± 8
 10 26 ± 26 25 ± 25
 40 11 ± 11 10 ± 10
 100 0 ± 0 0 ± 0
 400 0 ± 0 0 ± 0
50 0 68 ± 6 66 ± 6
 1 66 ± 9 66 ± 7
 4 42 ± 9 40 ± 9
 10 25 ± 23 22 ± 22
 40 0 ± 0 0 ± 0
 100 0 ± 0 0 ± 0
 400 0 ± 0 0 ± 0
as the eye or fin used as an internal negative control), and a 40× 
magnification would provide a better resolution for calcium and 
muscle displacement analysis.
Muscle displacement, which is equivalent to muscle movement 
or heart contraction, was imaged with a high-resolution differential 
interference contrast (DIC) microscope. Cytosolic calcium images 
from fluo-4 were captured at excitation and emission of 490 and 
516 nm, respectively. Cytosolic calcium images from fura-2 were 
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Treatment with dopamine or verapamil showed obvious changes 
in the patterns of heart contraction in anesthetized, but not in 
embedded, zebrafish.
Likewise, cytosolic calcium was concurrently studied for at least 
200 s. Line graphs were generated to observe the patterns of calcium 
oscillation in the zebrafish’s heart (Figure 4). The average changes 
in cytosolic calcium were plotted against time. Consistent with the 
previous report (Huisken et al., 2004; Ebert et al., 2005; Milan et al., 
2006; Arnaout et al., 2007; Chi et al., 2008), calcium oscillation 
was seen in the heart. At least 30 s after treatment with dopamine 
or verapamil, changes in amplitudes of calcium oscillation in the 
heart could be observed in anesthetized fish.
When the oscillation frequency of the heart contraction 
(Figure 5A) or cardiac cytosolic calcium (Figure 5B) was analyzed 
more closely, our data showed that neither dopamine (100 μg/mL) 
nor verapamil (4 μg/mL) had any effect in methylcellulose embed-
ded fish. The oscillation frequencies of the heart contraction in 
control, dopamine, and verapamil groups are not statistically sig-
nificant from one another. Likewise, there is no difference among 
control, dopamine, and verapamil groups on the frequency of the 
cytosolic calcium oscillation.
In anesthetized fish, dopamine caused a slight decrease in heart 
contraction frequency, and verapamil significantly repressed the 
oscillation frequency of the heart contraction (Figure 5C). The 
frequency of cardiac contraction was significantly repressed in 
the verapamil-treated group, as compared to the control group. 
The dopamine-treated group did not show a significant change 
in the frequency of myocardial contraction. Whereas effect of 
dopamine was minimal, verapamil significantly repressed cal-
cium frequency, compared to the control group (Figure 5D). 
The verapamil-treated group showed a repressed calcium fre-
quency compared to the control group. The dopamine-treated 
group did not show a significant decrease in the frequency of 
myocardial contraction.
When the oscillation amplitude of the heart contraction 
(Figure 5E) or cardiac cytosolic calcium (Figure 5F) was analyzed, 
our data showed that neither dopamine nor verapamil had any effect 
in methylcellulose embedded fish. The oscillation amplitudes of the 
heart contraction in control, dopamine, and verapamil groups are 
not statistically significant from one another. Likewise, there is no 
difference among control, dopamine, and verapamil groups on the 
amplitude of the cytosolic calcium oscillation.
In anesthetized fish, it is interesting to note that both dopamine 
and verapamil induced a significant increase in magnitude of heart 
muscle displacement (Figure 5G). The magnitude of cardiac con-
traction was significantly greater in dopamine (2.00 ± 0.40 unit) 
and verapamil-treated groups as compared to the control group. 
Whereas dopamine increased magnitude of calcium oscillation, 
verapamil significantly repressed it (Figure 5H). Compared to the 
control group, the amplitude of calcium oscillation was increased 
in the dopamine-treated group and decreased in the verapamil-
treated group.
While the frequency relationships between cytosolic calcium 
and heart contraction were consistent, the amplitude correlations 
between heart contraction and cytosolic calcium were unexpected 
in anesthetized fish (Figure 5). This is especially the case in the ver-
apamil-treated group. We have previously shown that the changes 
captured at an emission wavelength of 510 nm and excitation wave-
lengths of 340 and 380 nm. In some cases, DIC and fluorescence 
images were captured simultaneously. When fura-2 was used, fluo-
rescence images were captured for at least 200 s. Otherwise, images 
were capture at 26 frames/s for 3,000 frames.
data analysis
All measurements were done at the ventricular of the zebrafish’s 
heart. To avoid any movement artifact, all our data were com-
pared with the measurement of the eye and other organs, which 
serve as internal controls in each corresponding fish (Figure 2). 
To further avoid motion artifact, we also compared background 
fluorescence of hearts with and without calcium indicator. 
Furthermore, calcium analysis was done by first subtracting any 
background fluorescence. The frequency of heart oscillation was 
determined by measuring the peak-to-peak interval of the oscil-
lations for both cytosolic calcium and heart contraction. The 
magnitude of heart oscillation was measured by analyzing the 
peak-to-valley amplitude of the oscillations in both cytosolic 
calcium and muscle contraction. Data comparisons were done 
using ANOVA test followed by Tukey post-test analysis. Data are 
shown as mean ± standard error of mean with statistical power 
greater than 0.8 at p < 0.05.
results
In the present study, we show that zebrafish is an excellent model to 
study biological reflex in response to pharmacological agents such 
as dopamine and verapamil (Figure 1). To enable us to monitor 
heart muscle in zebrafish, fish were either embedded in methylcel-
lulose or anesthetized with tricaine. These techniques allow us to 
monitor heart muscle contraction, cytosolic calcium oscillation, 
and/or both. To examine the effects of inotropic agents on the 
fish heart, we used submaximal concentrations of both dopamine 
(100 μg/mL) and verapamil (4 μg/mL), which provide maximal 
effects in anesthetized fish without killing the fish.
Due to the transparent nature of the zebrafish, we were able 
to observe and record heart muscle displacement. Heart muscle 
movement was studied for about 200 s. As expected, no changes in 
muscle displacement or calcium fluctuation (Figure 2) were seen 
in the eye or other organs of the fish. The oscillation movement 
of the heart was plotted against time in line graphs (Figure 3). 
Table 2 | Effects of dopamine and propranolol on heart rate and calcium 
oscillation.
Dopamine Propranolol Heart rate Ca2+ oscillation 
(μg/mL) (μM) (beats/min) (oscillations/min)
  0 0 120 ± 6 118 ± 5
  0 0.001 107 ± 6 105 ± 6
100 0 132 ± 6 132 ± 5
100 0.001 116 ± 7 115 ± 7
100 0.01 103 ± 6 105 ± 4
100 0.1 96 ± 4 98 ± 3
100 1 40 ± 9 38 ± 9
100 3 29 ± 13 25 ± 10
100 10 0 ± 0 0 ± 0
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discussion
In the present study, we show that tricaine-anesthetized zebrafish 
becomes more sensitive in response to cardiovascular pharmaco-
logical agents. As we understand it, we are the first to examine 
the effects of pharmacological agents on both cardiac cytosolic 
calcium and myocardial contraction simultaneously in vivo in non-
transgenic 1-week-old zebrafish (Figure 1). We also demonstrate 
that pharmacological agents, such as verapamil, have the potential 
to change myocardial calcium sensitivity in anesthetized fish. To our 
knowledge, we provide the first in vivo evidence that verapamil may 
have a more complicated physiological reflex than simply blocking 
in the contractile force for a given cytosolic calcium concentration 
can be altered during cerebral development (Nauli et al., 2001a,b). 
The relationship between contractile force and cytosolic calcium is 
known as calcium sensitivity. Surprisingly, our data show that vera-
pamil significantly increased calcium sensitivity in the anesthetized 
zebrafish heart (Figure 6). In embedded fish, calcium sensitivity 
was not changed with treatment of either dopamine or verapamil, 
compared to the control group. In anesthetized fish, the calcium 
sensitivity in the verapamil-treated group is significantly greater 
than in the control group, whereas no difference is observed in the 
dopamine-treated group.
FigurE 1 | Live-imaging effects of dopamine and verapamil are studied in 
zebrafish heart. Fish was treated with vehicle (control), dopamine, or verapamil. 
The intracellular calcium and muscle oscillation of the heart were monitored and 
recorded. Fish heart was pseudocolored to show the changes in intracellular 
calcium, as indicated in color bar where low to high intracellular calcium levels 
were denoted in black and red colors, respectively. Images were captured at a 
rate of either 26 frames/s. The changes in cytosolic calcium are shown for about 
36 s at 4 s intervals, as indicated at the top left corner.
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and therefore is rapidly absorbed and eliminated by diffusion across 
the membranes of the gills (Kolanczyk et al., 2003). Tricaine is clas-
sified as a muscle relaxant that functions by blocking action poten-
tials, therefore causing a lack of signals being exchanged between 
the brain and surrounding areas (Kolanczyk et al., 2003). With the 
lack of action potentials, no sensory input or muscle contractions 
are present. For this reason, tricaine is primarily used to temporar-
ily immobilize fish, amphibians, and other aquatic cold-blooded 
animals to enable handling of these species during research.
At the correct concentration, tricaine can also be used for eutha-
nasia. For our purposes, we used tricaine at a concentration of 
50 μg/mL to enable monitoring of heart rate and contractility. This 
concentration of tricaine was optimal for the intended purpose. At 
this optimal concentration of tricaine, we observed a significant 
decrease in the heart rate of the zebrafish. Our experiences with 
tricaine show that it has a rapid anesthetic effect as well as a rapid 
recovery rate.
It has been shown that anesthesia can produce depressing effects 
on the cardiovascular system in both animal models and humans. 
For example, a study found that propofol moderately compromised 
cardiac contractility and increased afterload on the right ventricle, 
without significant effect on coronary perfusion pressure (Machala 
and Szebla, 2008). Although most cardiovascular compromise 
was clinically insignificant in the majority of general anesthetic, 
including propofol, certain combinations of anesthetic agents with 
other cardiovascular agents can cause additional effects or adverse 
effects. Our data, in particular, demonstrate that general anesthetic 
and combination of cardiovascular agents would increase sensi-
tivity toward cardiovascular response in fish. The mechanism by 
which this occurs may involve myofilament calcium sensitivity of 
heart muscle.
Dopamine is known to be a positive inotropic agent that 
acts on the dopaminergic receptors (Ricci et al., 1998). In the 
myocytes, the dopaminergic receptor (D4) activation, which is 
a G
i
-coupled receptor, will promote an increase in cytosolic cal-





 calcium channel and the plasmalemmal calcium channel 
through the Gβγ subunit (Ricci et al., 1998). The increase in intrac-
ellular calcium, which is a second messenger for the myosin–actin 
cross-bridge formation, will ultimately increase the contractile 
force. The inotropic characteristic of dopamine has been used 
in patients with advanced heart failure (Carey and Jacob, 1989). 
Consistent with this notion, dopamine increases myocardial 
muscle contraction in anesthetized fish (Figures 3 and 5). The 
enhanced heart muscle contraction is likely caused by dopamine-
induced cytosolic calcium increases (Figures 3–5). It is important 
to note that the rates and frequency of calcium oscillation are 
not significantly altered by dopamine. Consequently, dopamine 
does not significantly alter the frequency of heart contraction. 
Our data support the view that dopamine increases myocardial 
contractility and cardiac output without changing heart rate 
(Contreras et al., 2002).
Verapamil belongs to the phenylalkylamine class of L-type cal-
cium channel blockers. Verapamil has been used to treat cardiac 
arrhythmias, hypertension, and angina (Prisant, 2001), probably 
because the phenylalkylamine class has more selectivity in the heart 
than in peripheral vasculatures. Due to its site selectivity, we selected 
calcium channels. We have therefore offered a new way to further 
these studies with concurrent measurements of heart cytosolic cal-
cium and its role in myocardial contractility not only in developing 
fish but also in adult fish.
To enable us to monitor the heart of living fish, the fish was 
either embedded in methylcellulose or anesthetized with tricaine. 
In particular, tricaine is a frequently used as a general anesthetic for 
fish (Machin, 1999; Kolanczyk et al., 2003; Craig et al., 2006). This 
anesthetic agent is known to depress neuronal activity in the central 
and peripheral nervous systems (Machin, 1999; Kolanczyk et al., 
2003; Craig et al., 2006). In addition, tricaine is highly lipid-soluble, 
FigurE 2 | internal muscle movement and cytosolic calcium are studied 
in various organs of zebrafish. Internal organs of zebrafish were indicated by 
the corresponding text (A). A and V denote the atrium and ventricle of the 
heart, respectively. To verify the specificity of muscle contraction and calcium 
oscillation in the heart and to avoid any movement artifact, changes in muscle 
movement (B) and cytosolic calcium (C) of the corresponding fish were also 
measured in the eye. The eye measurement can therefore represent an 
internal negative control for cytosolic calcium recording.
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FigurE 3 | Effects of dopamine and verapamil on heart muscle contraction were examined in the zebrafish. Representatives of heart muscle displacement 
are shown in the embedded and anesthetized fish treated with vehicle (ctrl), dopamine (DA), or verapamil (VA).
FigurE 4 | Effects of dopamine and verapamil on cytosolic calcium oscillation were examined in the zebrafish. Representatives of calcium oscillation in the 
heart are shown in the embedded and anesthetized fish treated with vehicle (ctrl), dopamine (DA), or verapamil (VA).
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FigurE 5 | Effects of dopamine and verapamil on frequency and amplitude 
of cytosolic calcium and muscle contraction are quantified in zebrafish 
heart. The frequency of the heart oscillation was measured by analyzing the 
peak-to-peak interval of the oscillations in embedded (A,B) and anesthetized 
(C,D) fish. The frequencies of muscle contraction (A,C) and cytosolic calcium 
(B,D) were averaged in fish treated with the vehicle (ctrl), dopamine (DA), or 
verapamil (VA). Verapamil significantly decreases the frequency of oscillations of 
both cytosolic calcium and muscle contraction in anesthetized fish. The 
magnitude of the heart oscillation was measured by analyzing the peak-to-valley 
amplitude of the oscillations in embedded (E,F) and anesthetized (g,H) fish. The 
magnitudes of muscle contraction (E,g) and cytosolic calcium (F,H) were 
averaged accordingly. Both dopamine and verapamil significantly increase the 
magnitude of heart muscle contraction in the anesthetized zebrafish heart. While 
dopamine increases the amplitude of calcium, verapamil decreases the calcium 
amplitude in anesthetized fish. Asterisks denote a significant difference 
compared to control. N = 6.
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As it is apparently shown, increasing tricaine concentrations 
will enhance sensitivity of the fish to verapamil. Furthermore, 
because dopamine may also act through stimulation of beta-
adrenergic receptors, propranolol was used to analyze this 
possibility (Table 2). Our data exclude the possibility that 
dopamine acts through adrenergic receptors, because pro-
pranolol still shows a dose response effect on the heart in the 
presence of dopamine.
We use the 1-week-old zebrafish in our study for several reasons. 
First, the zebrafish at this age still have a transparent characteris-
tic that provides tremendous opportunity to study their internal 
organs. This characteristic provides us with the ability to measure 
heart contractility and cytosolic calcium. Second, the 1-week-old 
zebrafish has developed a well-defined cardiovascular system. 
Thus, the 1-week-old zebrafish shows a strong heartbeat and well-
defined cardiac muscle. Third, the 1-week-old zebrafish has mature 
cardiovascular responses, including responses to dopamine and 
verapamil observed in our experiments. In addition, the mature 
cardiovascular characteristics provide us with an advantage to 
study cardiovascular reflexes seen in the mammalian system. We 
believe that verapamil, which lowers the cytosolic calcium oscil-
lation in our experiments, also generates a reflex by increasing 
inotropic heart contraction.
Although myocardial calcium of the zebrafish has been previ-
ously studied, only the isolated heart was examined (Sehnert et al., 
2002; Sedmera et al., 2003; Langenbacher et al., 2005). The in vivo 
heart was studied in very young fish at about 48 h postfertilization 
(Huisken et al., 2004; Ebert et al., 2005; Milan et al., 2006; Arnaout 
et al., 2007; Chi et al., 2008). More importantly, no measurement 
of heart muscle displacement was ever recorded. However, one 
disadvantage of using an adult fish is that the anesthetization would 
significantly slow the heartbeat (Barrionuevo and Burggren, 1999). 
Despite this disadvantage, we would argue that the heart becomes 
more sensitive in response to pharmacological agents, as evidenced 
by our study.
Overall, our study reinforces the roles of dopamine and vera-
pamil in cardiac myocytes. We show that tricaine-anesthetized 
zebrafish become more sensitive in response to cardiovascular 
pharmacological agents, such dopamine and verapamil. Our 
data also suggest a possible verapamil-induced inotropic reflex 
through an increase in myocardial calcium sensitivity in anes-
thetized zebrafish.
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verapamil as a pharmacological candidate in our study. Our data 
show that verapamil decreases the frequency of calcium oscillation 
in the anesthetized zebrafish heart (Figures 4 and 5). Subsequently, 
verapamil’s inhibitory effect on cytosolic calcium reduces myocar-
dial heartbeat (Figure 5). It is expected that verapamil also decreases 
the amplitude of cytosolic calcium oscillation in the anesthetized 
zebrafish heart. However, it surprises us that verapamil significantly 
increases myocardial contraction. Reflex vasoconstriction has been 
proposed to be a compensatory mechanism for verapamil. Here we 
propose that verapamil can also induce reflex myocardial inotropic 
effects, at least in the zebrafish.
To help explain the molecular coupling of cytosolic calcium and 
myofilament contractility for verapamil, we revisit the molecu-
lar theory termed “calcium sensitivity.” The term explains that the 
efficiency of calcium-induced contraction can be regulated at the 
molecular level (McDaniel et al., 1994; Murphy and Walker, 1998). 
In particular, we and others have shown that the efficiency of utiliz-
ing calcium for contraction can be observed during cardiovascular 
development (Nauli et al., 2001a,b), pregnancy (Xiao et al., 2006), 
physiological perturbation (Mulvany and Nyborg, 1980), and so 
on. More importantly, physiological perturbation by verapamil also 
increases calcium sensitivity (Figure 6). Interestingly, dopamine 
does not promote significant changes in calcium sensitivity. One 
possible explanation is that a physiological reflex in response to 
verapamil has been initiated in the heart by tricaine to increase 
the heart muscle contraction. This reflex is probably necessary 
to prevent cardiovascular collapse due to a decreased heartbeat. 
Undoubtedly, this interesting phenomenon warrants more detailed 
studies in the future.
The effect of verapamil was further confirmed in anesthe-
tized fish by using different tricaine concentrations to exam-
ine changes in heart rate and calcium oscillation (Table 1). 
FigurE 6 | Verapamil causes a physiological reflex that induces calcium 
sensitivity in anesthetized zebrafish heart. Calcium sensitivity is defined as 
the contractile force produced by a given increase in cytosolic calcium. When 
the values of contractile forces were divided by the changes in cytosolic 
calcium, the myogenic calcium sensitivity increased significantly only in 
anesthetized fish treated with verapamil. This indicates that verapamil as a 
calcium channel blocker has a greater complexity in the myogenic heart 
contractility in response to anesthetic. Asterisk denotes a significant 
difference compared to control.
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